Thursday November 10, 2022 – 4:15 pm – Auditoire E

Mathilde BAUSART - Advanced Drug Delivery and Biomaterials (ADDB) Research Group

Combination of immunotherapy and local chemotherapy for the treatment of unresectable glioblastoma

Promotor: Véronique Préat

Co-promotor: Alessio Malfanti

Related publications:

• Bausart M, Vanvarenberg K, Ucakar B, Lopes A, Vandermeulen G, Malfanti A, Préat V. Combination of DNA vaccine and immune checkpoint blockades improves the immune response in an orthotopic unresectable glioblastoma model. Pharmaceutics 2022;14:1025.
• Bausart M, Préat V, Malfanti A. Immunotherapy for glioblastoma: the promise of combination strategies. J. Exp. Clin. Cancer Res. 2022;41:35.
• Lopes A*, Bastiancich C*, Bausart M, Ligot S, Lambricht L, Vanvarenberg K, Ucakar B, Gallez B, Préat V, Vandermeulen G. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models. J. Immunother. Cancer 2021;9:e001243.

Info: veronique.preat@uclouvain.be